Apps in this category may contain mild or occasional cartoon, fantasy or real-life violence, as well as occasional or mild adult, sexually suggestive or horrifying content and may not be suitable for children under 9 years of age.

12+

Apps in this category may contain occasional mild indecent language, frequent or intense cartoon or real-life violence, minor or occasional adult or sexually suggestive material, and simulated gambling, and may be for children under 12 years of age.

17+

You must be at least 17 years old to access this App.

Apps in this category may contain frequent and intense offensive language; Frequent and intense cartoon, fantasy or realistic violence: frequent and intense adult, scary and sexually suggestive subjects: as well as sexual content, nudity, tobacco, alcohol and drugs, may not be suitable for children under 17 years of age.

Amyloidosis Clinical Resources 스크린 샷

iPad

iPhone

About Amyloidosis Clinical Resources

Amyloidosis Diagnosis and Treatment App for healthcare professionals

A rare and challenging set of diseases including light chain (AL – kappa / lambda), transthyretin (hereditary, ATTR), secondary (AA) and wild-type (formerly called senile systemic), this app provides clinically relevant information that offers healthcare professionals a brief yet practical disease overview and interactive tools which can lead to earlier diagnosis and therapeutic intervention.

The content has been developed by Borm Bruckmeier Publishing in collaboration with the Amyloidosis Research Consortium and is intended for practicing physicians, resident physicians and other healthcare professionals involved in the diagnosis and treatment of patients with amyloidosis.
 
Highlights include:
• Descriptions of the most frequently seen types of amyloidosis
• Clinical presentations
• Signs and symptoms characteristic of amyloidosis
• Differential diagnoses
• Elements of the diagnostic workup including laboratory tests, biopsies, and genetic testing
• Treatment strategies including stem cell transplant, disease-modifying medications, clinical trials and novel agents
• Core treatment centres
• Clinical trials
• Comprehensive resources to share with patients including:
‣ Informative foundations and websites
‣ Support groups (USA and international)
‣ Treatment centers (USA and international)
‣ Educational webinars, disease pamphlets and guides
‣ Financial assistance for drugs and travel for treatment
‣ Caregiver resources